Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-12-13 Sale |
2023-12-14 4:07 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
610 | $870 | $530,700 | 1,247 (Direct) |
View |
2023-12-11 Sale |
2023-12-12 4:04 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
270 | $838.44 | $226,379 | 28,248 (Indirect Direct) |
View |
2023-12-05 Sale |
2023-12-06 4:02 pm |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
6,536 | $817.44 | $5,342,787 | 63,731 (Indirect Direct) |
View |
2023-12-01 Sale |
2023-12-04 4:02 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
100 | $817.3 | $81,730 | 18,447 (Direct) |
View |
2023-11-14 Sale |
2023-11-15 4:02 pm |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
6,492 | $799.17 | $5,188,213 | 83,731 (Indirect Direct) |
View |
2023-11-07 Sale |
2023-11-08 4:07 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
100 | $827.9 | $82,790 | 18,547 (Direct) |
View |
2023-11-01 Sale |
2023-11-02 4:03 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,000 | $783.91 | $783,910 | 28,961 (Indirect Direct) |
View |
2023-10-13 Sale |
2023-10-17 4:06 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Zoghbi Huda Y Director |
1,000 | $850 | $850,000 | 2,364 (Direct) |
View |
2023-10-02 Sale |
2023-10-03 4:04 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,038 | $827 | $858,426 | 23,373 (Indirect Direct) |
View |
2023-09-01 Sale |
2023-09-06 4:03 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
250 | $834.55 | $208,638 | 19,961 (Indirect Direct) |
View |
2023-08-23 Sale |
2023-08-25 4:02 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
223 | $844 | $188,212 | 31,969 (Indirect Direct) |
View |
2023-08-23 Sale |
2023-08-25 4:02 pm |
REGENERON PHARMACEUTICALS INC. | REGN | POON CHRISTINE A Director |
12,280 | $839.97 | $10,314,829 | 2,037 (Direct) |
View |
2023-08-24 Sale |
2023-08-25 4:02 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr, Industrial |
6,197 | $841.71 | $5,216,073 | 58,089 (Indirect Direct) |
View |
2023-08-22 Sale |
2023-08-23 4:03 pm |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
11,665 | $840.98 | $9,810,082 | 94,289 (Indirect Direct) |
View |
2023-08-21 Sale |
2023-08-23 4:03 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
853 | $829 | $707,137 | 2,101 (Direct) |
View |
2023-08-10 Sale |
2023-08-11 4:13 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
853 | $789 | $673,017 | 2,954 (Direct) |
View |
2023-08-01 Sale |
2023-08-03 4:25 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
100 | $736.59 | $73,659 | 18,647 (Direct) |
View |
2023-08-01 Sale |
2023-08-03 4:02 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
250 | $744.66 | $186,165 | 20,211 (Indirect Direct) |
View |
2023-07-03 Sale |
2023-07-06 4:02 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
250 | $710.09 | $177,523 | 20,460 (Indirect Direct) |
View |
2023-07-03 Sale |
2023-07-06 4:01 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
100 | $716.88 | $71,688 | 18,747 (Direct) |
View |
2023-06-01 Sale |
2023-06-02 4:14 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
100 | $735.42 | $73,542 | 18,847 (Direct) |
View |
2023-06-01 Sale |
2023-06-02 4:12 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
250 | $736 | $184,000 | 20,710 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-12-12 Tax Withholding |
2023-12-14 4:11 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
5,105 | $856.71 | 15,494 (Direct) |
View |
2023-12-12 Tax Withholding |
2023-12-14 4:10 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
7,657 | $856.71 | 52,616 (Direct) |
View |
2023-12-12 Tax Withholding |
2023-12-14 4:08 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller |
2,552 | $856.71 | 28,809 (Direct) |
View |
2023-12-12 Tax Withholding |
2023-12-14 4:08 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
6,381 | $856.71 | 40,968 (Direct) |
View |
2023-12-13 Exercise |
2023-12-14 4:08 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
1,000 | $378.98 | 40,968 (Direct) |
View |
2023-12-13 Tax Withholding |
2023-12-14 4:08 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
723 | $871.12 | 40,968 (Direct) |
View |
2023-12-13 Exercise |
2023-12-14 4:08 pm |
N/A 2027-12-12 |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
1,000 | $0 | 40,968 (Direct) |
View |
2023-12-13 Exercise |
2023-12-14 4:07 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
610 | $376.69 | 1,247 (Direct) |
View |
2023-12-13 Exercise |
2023-12-14 4:07 pm |
N/A 2027-01-03 |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
610 | $0 | 1,247 (Direct) |
View |
2023-12-11 Tax Withholding |
2023-12-13 4:05 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO |
12,841 | $844.09 | 1,234,704 (Direct) |
View |
2023-12-11 Exercise |
2023-12-13 4:05 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO |
25,155 | $0 | 1,234,704 (Direct) |
View |
2023-12-11 Tax Withholding |
2023-12-13 4:05 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO |
12,841 | $844.09 | 695,330 (Direct) |
View |
2023-12-11 Exercise |
2023-12-13 4:05 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO |
25,155 | $0 | 695,330 (Direct) |
View |
2023-12-11 Tax Withholding |
2023-12-12 4:05 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr, Industrial |
3,221 | $844.09 | 45,307 (Direct) |
View |
2023-12-08 Option Award |
2023-12-12 4:05 pm |
N/A 2033-12-08 |
REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr, Industrial |
14,672 | $0 | 45,307 (Direct) |
View |
2023-12-08 Tax Withholding |
2023-12-12 4:05 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr, Industrial |
1,108 | $843.79 | 45,307 (Direct) |
View |
2023-12-11 Tax Withholding |
2023-12-12 4:05 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
725 | $844.09 | 65,517 (Direct) |
View |
2023-12-08 Option Award |
2023-12-12 4:05 pm |
N/A 2033-12-08 |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
3,912 | $0 | 65,517 (Direct) |
View |
2023-12-08 Tax Withholding |
2023-12-12 4:05 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
809 | $843.79 | 65,517 (Direct) |
View |
2023-12-11 Tax Withholding |
2023-12-12 4:05 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
5,774 | $844.09 | 71,746 (Direct) |
View |
2023-12-08 Option Award |
2023-12-12 4:05 pm |
N/A 2033-12-08 |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
14,672 | $0 | 71,746 (Direct) |
View |
2023-12-08 Tax Withholding |
2023-12-12 4:05 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
883 | $843.79 | 71,746 (Direct) |
View |
2023-12-11 Tax Withholding |
2023-12-12 4:04 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
373 | $844.09 | 28,248 (Direct) |
View |
2023-12-08 Option Award |
2023-12-12 4:04 pm |
N/A 2033-12-08 |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
9,782 | $0 | 28,248 (Direct) |
View |
2023-12-08 Tax Withholding |
2023-12-12 4:04 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
852 | $843.79 | 28,248 (Direct) |
View |
2023-12-11 Tax Withholding |
2023-12-12 4:01 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret |
669 | $844.09 | 41,407 (Direct) |
View |
2023-12-08 Option Award |
2023-12-12 4:01 pm |
N/A 2033-12-08 |
REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret |
9,782 | $0 | 41,407 (Direct) |
View |
2023-12-08 Tax Withholding |
2023-12-12 4:01 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret |
852 | $843.79 | 41,407 (Direct) |
View |
2023-12-11 Tax Withholding |
2023-12-12 4:01 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
3,221 | $844.09 | 27,735 (Direct) |
View |
2023-12-08 Tax Withholding |
2023-12-12 4:01 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
1,013 | $843.79 | 27,735 (Direct) |
View |
2023-12-11 Tax Withholding |
2023-12-12 4:01 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller |
1,536 | $844.09 | 39,860 (Direct) |
View |
2023-12-08 Option Award |
2023-12-12 4:01 pm |
N/A 2033-12-08 |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller |
10,869 | $0 | 39,860 (Direct) |
View |
2023-12-08 Tax Withholding |
2023-12-12 4:01 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller |
474 | $843.79 | 39,860 (Direct) |
View |
2023-12-04 Exercise |
2023-12-06 4:02 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
20,000 | $270.43 | 63,731 (Direct) |
View |
2023-12-04 Tax Withholding |
2023-12-06 4:02 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
13,464 | $813.58 | 63,731 (Direct) |
View |
2023-12-04 Exercise |
2023-12-06 4:02 pm |
N/A 2023-12-13 |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
20,000 | $0 | 63,731 (Direct) |
View |
2023-11-13 Tax Withholding |
2023-11-15 4:02 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
13,508 | $795.69 | 83,731 (Direct) |
View |
2023-11-13 Exercise |
2023-11-15 4:02 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
20,000 | $270.43 | 83,731 (Direct) |
View |
2023-11-13 Exercise |
2023-11-15 4:02 pm |
N/A 2023-12-13 |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
20,000 | $0 | 83,731 (Direct) |
View |
2023-11-10 Gift |
2023-11-14 4:03 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
400 | $0 | 63,139 (Direct) |
View |
2023-11-01 Exercise |
2023-11-02 4:03 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,000 | $381.4 | 28,961 (Direct) |
View |
2023-11-01 Exercise |
2023-11-02 4:03 pm |
N/A 2028-12-12 |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,000 | $0 | 28,961 (Direct) |
View |
2023-10-13 Exercise |
2023-10-17 4:06 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Zoghbi Huda Y Director |
1,000 | $391.92 | 2,364 (Direct) |
View |
2023-10-13 Exercise |
2023-10-17 4:06 pm |
N/A 2026-09-09 |
REGENERON PHARMACEUTICALS INC. | REGN | Zoghbi Huda Y Director |
1,000 | $0 | 2,364 (Direct) |
View |
2023-10-02 Exercise |
2023-10-03 4:04 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,038 | $372.46 | 23,373 (Direct) |
View |
2023-10-02 Exercise |
2023-10-03 4:04 pm |
N/A 2029-12-11 |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,038 | $0 | 23,373 (Direct) |
View |
2023-09-08 Option Award |
2023-09-12 4:04 pm |
N/A 2033-09-08 |
REGENERON PHARMACEUTICALS INC. | REGN | Schenkein David P Director |
2,979 | $0 | 2,979 (Direct) |
View |
2023-09-08 Option Award |
2023-09-12 4:03 pm |
N/A 2033-09-08 |
REGENERON PHARMACEUTICALS INC. | REGN | Guarini Kathryn Director |
2,979 | $0 | 2,979 (Direct) |
View |
2023-08-23 Exercise |
2023-08-25 4:03 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller |
7,000 | $399.66 | 41,001 (Direct) |
View |
2023-08-23 Tax Withholding |
2023-08-25 4:03 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller |
5,198 | $842.66 | 41,001 (Direct) |
View |
2023-08-23 Exercise |
2023-08-25 4:03 pm |
N/A 2024-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller |
7,000 | $0 | 41,001 (Direct) |
View |
2023-08-23 Exercise |
2023-08-25 4:02 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | POON CHRISTINE A Director |
12,280 | $273.67 | 2,037 (Direct) |
View |
2023-08-23 Exercise |
2023-08-25 4:02 pm |
N/A 2024-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | POON CHRISTINE A Director |
12,280 | $0 | 2,037 (Direct) |
View |
2023-08-23 Exercise |
2023-08-25 4:02 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr, Industrial |
23,125 | $381.4 | 58,089 (Direct) |
View |
2023-08-23 Tax Withholding |
2023-08-25 4:02 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr, Industrial |
16,928 | $842.66 | 58,089 (Direct) |
View |
2023-08-23 Exercise |
2023-08-25 4:02 pm |
N/A 2028-12-12 |
REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr, Industrial |
23,125 | $0 | 58,089 (Direct) |
View |
2023-08-21 Exercise |
2023-08-23 4:03 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
50,000 | $399.66 | 94,289 (Direct) |
View |
2023-08-21 Tax Withholding |
2023-08-23 4:03 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
38,335 | $833.39 | 94,289 (Direct) |
View |
2023-08-21 Exercise |
2023-08-23 4:03 pm |
N/A 2024-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
50,000 | $0 | 94,289 (Direct) |
View |
2023-08-21 Exercise |
2023-08-23 4:03 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
853 | $391.92 | 2,101 (Direct) |
View |
2023-08-21 Exercise |
2023-08-23 4:03 pm |
N/A 2026-09-09 |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
853 | $0 | 2,101 (Direct) |
View |
2023-08-10 Exercise |
2023-08-11 4:13 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
853 | $391.92 | 2,954 (Direct) |
View |
2023-08-10 Exercise |
2023-08-11 4:13 pm |
N/A 2026-09-09 |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
853 | $0 | 2,954 (Direct) |
View |